|
Programme
| 09.00 – 09.10 | Welcome & Introduction M. Brune (Göteborg, Sweden), C. Bergdahl (Skara, Sweden), D. Niederwieser (Leipzig, Germany) |
| 09.10 – 09.20 | Overview of transplant activity and scientific trends Speaker: D. Niederwieser (Leipzig, Germany) |
| 09.20 – 09.30 | Nurses role in care and science Speaker: E. Aerts (Zurich, Switzerland) |
| 09.30 – 10.45 | Plenary Session 1: Protecting the interest of donors and patients Chair: A. Gratwohl (Basel, Switzerland) |
| 09.35 – 10.00 | Protecting the integrity of the adult sibling donor Speaker: A. Kisch (Lund, Sweden) |
| 10.00 – 10.10 | Questions and discussion |
| 10.10 – 10.35 | The purpose and importance of patients’ associations Speakers: A. Waldmann (Ruesselsheim, Germany), C. Bergdahl (Skara, Sweden) |
| 10.35 – 10.45 | Questions and discussion |
| 10.45 – 11.15 | Coffee break |
| 11.15 – 12.30 | Plenary Session 2: Effects of cancer diagnosis and treatment Chair: J. Apperley (London, United Kingdom) |
| 11.20 – 11.45 | Cancer diagnosis, body image and intimacy Speaker: K. Bergmark (Stockholm, Sweden) |
| 11.45 – 11.55 | Questions and discussion |
| 11.55 – 12.20 | Sexual problems and chronic GvHD after allo-transplant Speaker: E. Smith Knutsson (Trollhättan, Sweden) |
| 12.20 – 12.30 | Questions and discussion |
| 12.30 – 13.30 | Lunch break |
| 13.30 – 14.15 | Plenary Session 3: What my family and I wish we had known beforehand Chair: E. Wallhult (Göteborg, Sweden) |
| Patients and families’ experiences, commented by transplant doctors Speakers: Two patients (to be selected), and two transplant doctors (S. Lenhoff, Lund, Sweden and T. Kiss, Montreal, Canada) |
|
| Questions and discussion | |
| 14.15 – 15.15 | Workshop 1 Acute leukaemias Chair: P.-O. Andersson (Göteborg, Sweden) Speaker: J. Finke (Freiburg, Germany) |
| 14.15 – 15.15 | Workshop 2 Myeloma Chair: S. Lenhoff (Lund, Sweden) Speaker: U-H. Mellqvist (Göteborg, Sweden) |
| 15.15 – 15.30 | Coffee break |
| 15.30 – 16.30 | Workshop 3 Lymphoma, chronic lymphocytic leukaemia Chair: E. Kimby (Huddinge, Sweden) Speaker: H. Hägglund (Huddinge, Sweden) |
| 15.30 – 16.30 | Workshop 4 Chronic myelogenous leukaemia Chair: H. Wadenvik (Göteborg, Sweden) Speaker: J. Apperley (London, United Kingdom) |
| 16.30 – 16.45 | Conclusions and Comments Chairs: A. Waldmann (Ruesselsheim, Germany), S. Lenhoff (Lund, Sweden), I. Andersson (Göteborg, Sweden), C. Bergdahl (Skara, Sweden) |
| 16.45 | Networking Get-Together between European patients’ associations |
All presentationswill be provided in English and Swedish (simultaneous translation). |